We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+14.52%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$247M
AUM Growth
+$26.9M
Cap. Flow
+$1.99M
Cap. Flow %
0.81%
Top 10 Hldgs %
28.64%
Holding
82
New
13
Increased
21
Reduced
29
Closed
19

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$5.2M
2
VTRS icon
Viatris
VTRS
+$4.79M
3
GILD icon
Gilead Sciences
GILD
+$4.11M
4
UNH icon
UnitedHealth
UNH
+$4.05M
5
ESRX
Express Scripts Holding Company
ESRX
+$3.65M

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$5.03M
2
EVHC
Envision Healthcare Holdings Inc
EVHC
+$4.33M
3
WBA
Walgreens Boots Alliance
WBA
+$4.15M
4
COR icon
Cencora
COR
+$3.44M
5
TMH
Team Health Holdings Inc
TMH
+$2.9M

Sector Composition

Rank Sector Weight
1 Healthcare 89.54%
2 Industrials 0.78%
3 Energy 0.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRNX
26
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$3.79M 1.54%
148,700
+8,700
+6% +$222K
GILD icon
27
Gilead Sciences
GILD
$168B
$3.74M 1.52%
+39,700
New +$4.11M
CNC icon
28
Centene
CNC
$33B
$3.69M 1.49%
142,000
-58,000
-29% -$1.35M
ALXN
29
DELISTED
Alexion Pharmaceuticals
ALXN
$3.66M 1.48%
19,800
-5,200
-21% -$964K
HSP
30
DELISTED
HOSPIRA INC
HSP
$3.64M 1.48%
59,500
-5,500
-8% -$311K
COR icon
31
Cencora
COR
$63.2B
$3.6M 1.46%
39,900
-40,100
-50% -$3.44M
TEVA icon
32
Teva Pharmaceuticals
TEVA
$43B
$3.41M 1.38%
59,300
+4,300
+8% +$240K
CVS icon
33
CVS Health
CVS
$122B
$3.34M 1.35%
+34,700
New +$3.06M
PRGO icon
34
Perrigo
PRGO
$1.76B
$3.31M 1.34%
+19,800
New +$3.1M
JAZZ icon
35
Jazz Pharmaceuticals
JAZZ
$16.6B
$3.24M 1.31%
19,800
-5,200
-21% -$863K
CAH icon
36
Cardinal Health
CAH
$58.2B
$3.19M 1.29%
39,500
-30,500
-44% -$2.41M
LPNT
37
DELISTED
LifePoint Health, Inc.
LPNT
$3.19M 1.29%
44,300
-20,700
-32% -$1.43M
SCAI
38
DELISTED
Surgical Care Affiliates, Inc.
SCAI
$3.16M 1.28%
94,000
-20,869
-18% -$642K
HRC
39
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$3.13M 1.27%
68,700
-1,300
-2% -$57.6K
ZTS icon
40
Zoetis
ZTS
$31.1B
$2.99M 1.21%
69,400
+9,400
+16% +$381K
MDVN
41
DELISTED
MEDIVATION, INC.
MDVN
$2.98M 1.21%
59,800
+9,800
+20% +$509K
MOH icon
42
Molina Healthcare
MOH
$10.4B
$2.9M 1.17%
54,200
-10,800
-17% -$523K
AMED
43
DELISTED
Amedisys
AMED
$2.79M 1.13%
95,200
-4,800
-5% -$119K
UAM
44
DELISTED
Universal American Corp
UAM
$2.76M 1.12%
297,400
-2,600
-0.9% -$22.6K
ILMN icon
45
Illumina
ILMN
$28.9B
$2.73M 1.11%
15,214
+5,962
+64% +$1.05M
BMRN icon
46
BioMarin Pharmaceuticals
BMRN
$13.6B
$2.69M 1.09%
29,800
+9,800
+49% +$815K
AMN icon
47
AMN Healthcare
AMN
$1.36B
$2.68M 1.08%
136,600
-63,400
-32% -$1.09M
ISRG icon
48
Intuitive Surgical
ISRG
$141B
$2.59M 1.05%
44,100
-23,400
-35% -$1.3M
INCY icon
49
Incyte
INCY
$24.7B
$2.54M 1.03%
34,700
+9,700
+39% +$634K
ENDP
50
DELISTED
Endo International plc
ENDP
$2.5M 1.01%
34,700
-10,300
-23% -$706K
1
2
3 4

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return

Sivik Global Healthcare's Q4 2014 Portfolio in Review

As of Q4 2014, Sivik Global Healthcare held 82 positions worth $247M, up 12% from $220M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Sivik Global Healthcare's Q4 2014 filing shows 13 new, 21 increased, 29 reduced and 19 closed positions. Its largest new stake was Becton Dickinson: 40,693 shares worth $5.53M. The largest sale was Labcorp, an estimated $5.03M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 89% a quarter earlier, followed by Industrials and Energy.

  • Sivik Global Healthcare's largest Q4 2014 buy was Becton Dickinson: 40,693 shares worth $5.53M.
  • Sivik Global Healthcare added most to Celgene Corp in Q4 2014, an estimated $3.3M increase.
  • Sivik Global Healthcare's biggest Q4 2014 reduction was Cencora, cutting an estimated $3.44M.
  • Sivik Global Healthcare fully exited Labcorp in Q4 2014, selling an estimated $5.03M.
  • Sivik Global Healthcare's ten largest holdings make up 29% of its $247M portfolio in Q4 2014.
  • Sivik Global Healthcare opened 13 new positions and closed 19 in Q4 2014.
  • Sivik Global Healthcare's portfolio value rose 12% quarter-over-quarter to $247M.

Based on Sivik Global Healthcare's 13F filing for Q4 2014, filed 7 Jan 2015.